| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M200729200 |
| P698 | PubMed publication ID | 11940583 |
| P50 | author | Michel Bouvier | Q38326685 |
| Stephane Angers | Q42889228 | ||
| Mohammed A Ayoub | Q56523147 | ||
| P2093 | author name string | Cyril Couturier | |
| Ralf Jockers | |||
| Philippe Fossier | |||
| Estelle Lucas-Meunier | |||
| P433 | issue | 24 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bioluminescence | Q179924 |
| melatonin | Q180912 | ||
| P304 | page(s) | 21522-8 | |
| P577 | publication date | 2002-06-14 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Monitoring of ligand-independent dimerization and ligand-induced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer | |
| P478 | volume | 277 |
| Q41125183 | A proteomic analysis reveals the interaction of GluK1 ionotropic kainate receptor subunits with Go proteins. |
| Q35625359 | AKAPs (A-kinase anchoring proteins) and molecules that compose their G-protein-coupled receptor signalling complexes |
| Q40649626 | Activation of the Leptin Receptor by a Ligand-induced Conformational Change of Constitutive Receptor Dimers |
| Q34164718 | An improved bioluminescence resonance energy transfer strategy for imaging intracellular events in single cells and living subjects |
| Q37233054 | Antibodies against G-protein coupled receptors: novel uses in screening and drug development |
| Q36498179 | Application of bioluminescence resonance energy transfer (BRET) for biomolecular interaction studies |
| Q36474528 | Are G protein-coupled receptor heterodimers of physiological relevance?--Focus on melatonin receptors |
| Q36750306 | BRET Biosensor Analysis of Receptor Tyrosine Kinase Functionality |
| Q43049511 | BRET analysis of GPCR oligomerization: newer does not mean better |
| Q80092854 | Bioluminescence resonance energy transfer (BRET) for the real-time detection of protein-protein interactions |
| Q39617143 | Bioluminescence resonance energy transfer reveals the adrenocorticotropin (ACTH)-induced conformational change of the activated ACTH receptor complex in living cells |
| Q92615461 | Bioluminescence resonance energy transfer-based imaging of protein-protein interactions in living cells |
| Q37773024 | Brain receptor mosaics and their intramembrane receptor-receptor interactions: molecular integration in transmission and novel targets for drug development |
| Q39845339 | Chapter 10. Hetero-oligomerization of chemokine receptors |
| Q44356748 | Characterization of the molecular interactions of interleukin-8 (CXCL8), growth related oncogen alpha (CXCL1) and a non-peptide antagonist (SB 225002) with the human CXCR2. |
| Q37236116 | Cofactoring and dimerization of proteinase-activated receptors |
| Q36504159 | Cone Viability Is Affected by Disruption of Melatonin Receptors Signaling |
| Q33292564 | Constitutive dimerization of human serotonin 5-HT4 receptors in living cells |
| Q24644172 | Constitutive dimerization of the G-protein coupled receptor, neurotensin receptor 1, reconstituted into phospholipid bilayers |
| Q42046489 | Constitutive oligomerization of human D2 dopamine receptors expressed in Spodoptera frugiperda 9 (Sf9) and in HEK293 cells. Analysis using co-immunoprecipitation and time-resolved fluorescence resonance energy transfer |
| Q37922648 | Cross-talk and modulation of signaling between somatostatin and growth factor receptors |
| Q36339155 | Current methods used to investigate G protein coupled receptor oligomerisation |
| Q39454848 | Description of the constitutive activity of cloned human melatonin receptors hMT(1) and hMT(2) and discovery of inverse agonists |
| Q40011961 | Differential Effects of Camel Milk on Insulin Receptor Signaling - Toward Understanding the Insulin-Like Properties of Camel Milk |
| Q51799487 | Dimerization between vasopressin V1b and corticotropin releasing hormone type 1 receptors. |
| Q35592680 | Dimerization of G-protein-coupled receptors: roles in signal transduction |
| Q34922254 | Dimerization, ubiquitylation and endocytosis go together in growth hormone receptor function |
| Q40188327 | Direct assessment of CXCR4 mutant conformations reveals complex link between receptor structure and G(alpha)(i) activation. |
| Q33520987 | Divergence of allosteric effects of rapacuronium on binding and function of muscarinic receptors |
| Q34502043 | Enabling systematic interrogation of protein-protein interactions in live cells with a versatile ultra-high-throughput biosensor platform |
| Q34979041 | Endospanins regulate a postinternalization step of the leptin receptor endocytic pathway |
| Q36191579 | Entropy and oligomerization in GPCRs |
| Q42489187 | Evidence for RGS4 modulation of melatonin and thyrotrophin signalling pathways in the pars tuberalis |
| Q24305045 | Evidence for leptin receptor isoforms heteromerization at the cell surface |
| Q38229317 | Expression and putative functions of melatonin receptors in malignant cells and tissues |
| Q34478976 | FRET imaging reveals that functional neurokinin-1 receptors are monomeric and reside in membrane microdomains of live cells |
| Q33935146 | First BRET-based screening assay performed in budding yeast leads to the discovery of CDK5/p25 interaction inhibitors. |
| Q35040371 | Follice-stimulating hormone receptor forms oligomers and shows evidence of carboxyl-terminal proteolytic processing |
| Q50733446 | G protein-coupled receptors: from ligand identification to drug targets. 14-16 October 2002, San Diego, CA, USA. |
| Q35630448 | G-protein coupled receptor oligomerization in neuroendocrine pathways |
| Q34932201 | G-protein-coupled receptor oligomerization and its potential for drug discovery |
| Q35581454 | GFP technology for live cell imaging |
| Q35579623 | GPCR dimerisation |
| Q21093414 | GPR50 is the mammalian ortholog of Mel1c: evidence of rapid evolution in mammals |
| Q57093573 | Genetic variations of the melatonin pathway in patients with attention-deficit and hyperactivity disorders |
| Q24338580 | Hetero-oligomerization between beta2- and beta3-adrenergic receptors generates a beta-adrenergic signaling unit with distinct functional properties |
| Q36497422 | Heterodimerization with the prostacyclin receptor triggers thromboxane receptor relocation to lipid rafts |
| Q37401735 | Heteromeric MT1/MT2 melatonin receptors modulate photoreceptor function |
| Q37819146 | Heterophilic chemokine receptor interactions in chemokine signaling and biology |
| Q28185834 | High-content assays for ligand regulation of G-protein-coupled receptors |
| Q28209959 | Homo- and hetero-oligomerization of thyrotropin-releasing hormone (TRH) receptor subtypes. Differential regulation of beta-arrestins 1 and 2 |
| Q33640009 | Identification of pathway-biased and deleterious melatonin receptor mutants in autism spectrum disorders and in the general population |
| Q34496062 | Illuminating insights into protein-protein interactions using bioluminescence resonance energy transfer (BRET). |
| Q37551248 | Illuminating the life of GPCRs |
| Q39967814 | Improved donor/acceptor BRET couples for monitoring beta-arrestin recruitment to G protein-coupled receptors |
| Q37431269 | Inhibition of heterotrimeric G protein signaling by a small molecule acting on Galpha subunit |
| Q24623433 | International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors |
| Q47612221 | Intracellular Trafficking of Gonadotropin Receptors in Health and Disease |
| Q33492319 | Lipid raft-mediated regulation of G-protein coupled receptor signaling by ligands which influence receptor dimerization: a computational study |
| Q37983474 | MC4R dimerization in the paraventricular nucleus and GHSR/MC3R heterodimerization in the arcuate nucleus: is there relevance for body weight regulation? |
| Q42321440 | Mathematical models for quantitative assessment of bioluminescence resonance energy transfer: application to seven transmembrane receptors oligomerization |
| Q39081184 | Melatonin MT₁ and MT₂ receptors display different molecular pharmacologies only in the G-protein coupled state. |
| Q36820392 | Melatonin and pancreatic islets: interrelationships between melatonin, insulin and glucagon |
| Q38256218 | Melatonin in sperm biology: breaking paradigms |
| Q35784330 | Melatonin membrane receptors in peripheral tissues: distribution and functions |
| Q48259203 | Melatonin receptor expression in the zebra finch brain and peripheral tissues |
| Q91827350 | Melatonin receptor heterodimerization in a photoreceptor-like cell line endogenously expressing melatonin receptors |
| Q36790172 | Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new? |
| Q39434518 | Melatonin receptors: molecular pharmacology and signaling in the context of system bias. |
| Q41952507 | Melatonin signaling in mouse cerebellar granule cells with variable native MT1 and MT2 melatonin receptors |
| Q35689110 | Melatonin: an inhibitor of breast cancer |
| Q36291423 | Melatonin: an underappreciated player in retinal physiology and pathophysiology |
| Q35749944 | Molecular basis for the chloride channel activity of cystic fibrosis transmembrane conductance regulator and the consequences of disease-causing mutations |
| Q24300492 | Molecular organization and dynamics of the melatonin MT₁ receptor/RGS20/G(i) protein complex reveal asymmetry of receptor dimers for RGS and G(i) coupling |
| Q34361815 | Monitoring the formation of dynamic G-protein-coupled receptor-protein complexes in living cells |
| Q27006763 | Neuroendocrine control of photoperiodic changes in immune function |
| Q39198879 | Neuronal signaling repertoire in the mammalian sperm functionality |
| Q35671415 | New technologies: bioluminescence resonance energy transfer (BRET) for the detection of real time interactions involving G-protein coupled receptors |
| Q40797679 | Oligomeric size of the m2 muscarinic receptor in live cells as determined by quantitative fluorescence resonance energy transfer |
| Q34257384 | Oligomerisation of C. elegans olfactory receptors, ODR-10 and STR-112, in yeast |
| Q35546811 | Oligomerization of G protein-coupled receptors: past, present, and future |
| Q34232914 | Oligomerization of G-protein-coupled receptors: lessons from the yeast Saccharomyces cerevisiae |
| Q35192340 | Opioid receptor interactions: local and nonlocal, symmetric and asymmetric, physical and functional |
| Q34399823 | Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders |
| Q40205844 | Opsin oligomerization in a heterologous cell system |
| Q38615371 | Orphan GPR61, GPR62 and GPR135 receptors and the melatonin MT2 receptor reciprocally modulate their signaling functions |
| Q38166623 | Pathophysiology of GPCR Homo- and Heterodimerization: Special Emphasis on Somatostatin Receptors |
| Q35606973 | Pharmacological chaperones for misfolded gonadotropin-releasing hormone receptors |
| Q34098252 | Physical and functional interaction between CB1 cannabinoid receptors and beta2-adrenoceptors |
| Q39017581 | Preferential recognition of monomeric CCR5 expressed in cultured cells by the HIV-1 envelope glycoprotein gp120 for the entry of R5 HIV-1. |
| Q28118188 | Protein interactome mining defines melatonin MT1 receptors as integral component of presynaptic protein complexes of neurons |
| Q34600176 | Purification and identification of G protein-coupled receptor protein complexes under native conditions. |
| Q38606734 | Quinone reductase 2 as a promising target of melatonin therapeutic actions. |
| Q37173576 | Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes |
| Q55464705 | Receptor-Receptor Interactions of G Protein-Coupled Receptors in the Carotid Body: A Working Hypothesis. |
| Q40477472 | Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease. |
| Q34868690 | Relationship between homo-oligomerization of a mammalian olfactory receptor and its activation state demonstrated by bioluminescence resonance energy transfer |
| Q34051430 | Role of Antibodies in Developing Drugs That Target G‐Protein‐Coupled Receptor Dimers |
| Q35622424 | Roles of G-protein-coupled receptor dimerization |
| Q34294075 | Sensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system |
| Q40253042 | Serotonin 5-HT2C receptor homodimer biogenesis in the endoplasmic reticulum: real-time visualization with confocal fluorescence resonance energy transfer |
| Q42324385 | Setting Up a Bioluminescence Resonance Energy Transfer High throughput Screening Assay to Search for Protein/Protein Interaction Inhibitors in Mammalian Cells |
| Q24301625 | Silencing of OB-RGRP in mouse hypothalamic arcuate nucleus increases leptin receptor signaling and prevents diet-induced obesity |
| Q46427683 | Stimulation of melatonin receptors decreases calcium levels in xenopus tectal cells by activating GABA(C) receptors |
| Q31144738 | Structure-based analysis of GPCR function: evidence for a novel pentameric assembly between the dimeric leukotriene B4 receptor BLT1 and the G-protein |
| Q36345018 | Subcellular imaging of dynamic protein interactions by bioluminescence resonance energy transfer |
| Q46672501 | The PDZ protein mupp1 promotes Gi coupling and signaling of the Mt1 melatonin receptor |
| Q24675155 | The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts |
| Q92359530 | The five dimensions of receptor pharmacology exemplified by melatonin receptors: An opinion |
| Q24293767 | The orphan GPR50 receptor specifically inhibits MT1 melatonin receptor function through heterodimerization |
| Q35945875 | The pattern of melatonin receptor expression in the brain may influence antidepressant treatment |
| Q34647965 | The use of resonance energy transfer in high-throughput screening: BRET versus FRET. |
| Q43146165 | The vasoactive peptides urotensin II and urotensin II-related peptide regulate astrocyte activity through common and distinct mechanisms: involvement in cell proliferation |
| Q33717398 | Transitioning pharmacoperones to therapeutic use: in vivo proof-of-principle and design of high throughput screens. |
| Q34118849 | Understanding melatonin receptor pharmacology: latest insights from mouse models, and their relevance to human disease |
| Q38868297 | Update on melatonin receptors: IUPHAR Review 20. |
| Q36035554 | Use of BRET to Study Protein-Protein Interactions In Vitro and In Vivo |
| Q33636647 | V1b and CRHR1 receptor heterodimerization mediates synergistic biological actions of vasopressin and CRH. |
Search more.